INTRODUCTION
Syzygium cumini L. (Myrtaceae), locally known as Jamun, is well-known plant for its nutritional and medicinal properties. Almost every part of the plant is used medicinally [1] [2] , however, the seeds in sweetish-sour berries are the most important one being used to treat a variety of ailments especially diabetes mellitus [3] . Seed powder in combination with mango kernels is reported to be effective for treating diarrhea, dysentery, spleen enlargement and enurea [3, 4] .
Other parts of the plant have also been exploited by natural product researchers for their antioxidant, anti-inflammatory, gastroprotective, anti-fertility [3] , antibacterial [5, 6] , antipyretic [7] , anticonvulsant [8] , and antineoplastic [9] potentials. To the best of our literature review, no report on pharmacokinetics studies of extracts of the seed was found.
Pharmacokinetics evaluation of the drug has a pivotal role in selection of its route of administration, dose, dosing interval and exposure, etc. In the recent past, this neglected aspect of natural products has grasped the attention of researchers, which is evident by a number of pharmacokinetics studies of plantbased products/extracts [10] [11] [12] . Unlike pharmaceuticals, phytopharmaceuticals are a mixture of known and mostly unknown components, hence are difficult to be investigated for pharmacokinetics. Another limitation is lack of analytical methods and unavailability of analytical standards. Li et al categorized markers into eight categories, which may be used as analytical standards [13] .
The seeds contain caffeic acid which is a polyphenolic compound possessing antioxidant [14] , immunomodulatory [15] , antimicrobial [16] , antiaging [17] , anti-inflammatory [18] and antidiabetic [19] activities. Therefore, the aim of this study is to use caffeic acid ( Figure 1 ) as an analytical marker to investigate its pharmacokinetics from extracts of seeds of Syzygium cumini. 
EXPERIMENTAL

Chemicals and solvents
Caffeic acid (Sigma Aldrich), HPLC grade methanol and acetonitrile (Merck, Germany), EDTA coated blood collection tubes and disposable syringes (BD) and 0.45 µm pore PTFE filters (Whatman, Maidstone, England) were procured from the local supplier. Ultrapurified water (HPLC grade) was prepared in the laboratory.
Plant materials
In May 2010, 28 kg ripe berries of the plant were purchased from the fruit market of Multan, Pakistan. The material was authenticated by Prof Dr Zaheer ud Din Khan (a taxonomist), Department of Botany, Government College University (GCU), Lahore, Pakistan. A voucher specimen (no. G. C. Bot. Herb 853) was deposited in the herbarium of GCU. The seeds were separated, washed with water and dried in an oven at 50 o C. The material was then crushed using colloidal mill, dried under shade for 4 weeks and pulverized. Five hundred grams powdered material was extracted sequentially by Soxhlet apparatus using petroleum ether, chloroform and methanol. The extracts were filtered and dried in vacuo at 40 o C.
Development and validation of HPLC method
Extraction of caffeic acid from plasma
Rat plasma (500 µL) was spiked with 500 µL caffeic acid solution (100 µg/mL) and mixed by vortex for 1min. Then, 200 µL acetonitrile was added and mixed by vortex for 5 s. Finally, 800 µL methanol was added and mixed by vortex for 5 s. The contents were subjected to centrifugation at 2700 rpm for 10 min at 25 o C. The supernatant was collected, dried with liquid nitrogen and the residue was reconstituted with 100 µL methanol.
High Performance Liquid Chromatography (HPLC)
HPLC system (1200 series, Agilent Technologies, Waldronn, Germany), equipped with degasser (G1379 A), quaternary pump (G1310 A), auto sampler (G1329 A), column oven (G1316 A) and florescent light detector (G 1321 A) was used in the study. The system was operated with LC/MS ChemStation software.
Chromatographic conditions
A volume of the sample/standard (20 µL) was eluted through column -Eclipse X DB-C18 (5 µm, 4.6 X 150 mm) -at flow rate of 1.0 mL/min, using isocratic mobile phase; water : acetonitrile : acetic acid (79 : 20 : 1.0, v/v/v). The column was maintained at 25 o C and the detection was carried out using florescent light detector (FLD); operated at 250 nm excitation and 410 nm emission.
Validation studies
Linearity
The rat plasma samples were spiked by caffeic acid solutions having concentration 2.5, 5.0, 10.0, 25.0, 50.0 and 100.0 µg/mL and extracted as mentioned above. The resulting samples were analyzed in triplicate at the mentioned chromatography conditions. The response of the detector (peak height) was plotted against the respective concentration and linearity was evaluated visually by observing the correlation coefficient.
Recovery, accuracy and precision
Three concentrations of caffeic acid solution (2.5, 50.0 and 100.0 µg/mL) were used to determine recovery, accuracy and precision. After spiking the plasma and extraction, the three samples were analyzed in triplicate and amount of caffeic acid was determined from the calibration curve. The determined amount was compared to the true value (spiked amount) and presented as % mean recovery ± SD.
For intraday accuracy and precision, each of the three standard solutions was analyzed in the same day for six times at chromatographic conditions mentioned above and the amount calculated from the calibration curve was compared to the true value to determine accuracy. Relative standard deviation was calculated as precision.
For inter day accuracy and precision, each of the three standard solutions was analyzed once daily for six consecutive days. The amount of the drug was determined from the calibration curve on each day. The determined values were used to assess accuracy and precision.
Robustness
The samples were analyzed by changing mobile phase composition (±2 %), Column temperature (±1 %) and detector parameters; excitation (±3 nm) and emission (±3 nm).
Pharmacokinetic studies
The study was conducted as per the research protocol approved by Animal Ethics Committee, University College of Pharmacy, University of the Punjab, Lahore, Pakistan (ref no. D/AEC/UCP/1027/4313).
Animals
Six, male, Wistar rats, weighing 200 ± 10 g, taken from University of Veterinary and Animal Sciences, Lahore, Pakistan, were allowed to acclimatize for seven days at Animal House, University College of Pharmacy, University of the Punjab, Lahore, Pakistan. Standard pellet diet and tap water were provided ad libitum. The animals were handled using Guideline 22 for the Housing of Mice in Scientific Institutions20.
Dose preparation and administration
The dried methanol extract having 74.27 mg/g caffeic acid was suspended in 1:1 (v/v) mixture of water and polyethylene glycol (PEG-400) to get a solution having concentration 250 mg/mL. Then, 2 mL suspension (500 mg extract, equivalent to 37.135 mg caffeic acid) was administered orally to each rat.
Blood sampling
From each rat, 0.5 mL blood was taken from the tail vein at 0 h (pre dose), 0.25, 0.50, 1.00, 2.00, 4.00 and 12.00 h. The plasma was collected after centrifugation of blood at 2700rpm for 10 min at 25 o C, which was then processed and analyzed as mentioned above.
Determination of pharmacokinetic parameters
Analytical data of each rat were used to plot a curve between plasma concentration of caffeic acid and time. Total area under the plasma concentration time curve (AUC 0-∞ ) was calculated using the trapezoidal rule and as in Eqs 1 and 2.
AUC 0-∞ = ∑ (AUC 0-1 +AUC 1-last +AUC last-∞ ) …… (1) AUC last-∞ = C last /K el …………….……………… (2) A plot between a cross product of concentration and time (CT) was used to calculate the area under the first moment curve (AUMC). Mean resident time (MRT) was obtained by dividing AUMC 0-∞ with AUC 0-∞ .
The maximum plasma concentration (C max , ng/mL) and time to it (T max ) were taken directly from plot. The elimination rate constant (K el , h -1 ) was calculated by the linear regression on the terminal phase of the plasma concentration time plot and using Eq 3.
The half-life (t 1/2 ) was calculated by dividing 0.693 with K el , while clearance (Cl) and volume of distribution (VD) were determined as in Eqs 4 and 5. 
Statistical analysis
The samples were analyzed in triplicate and the results were presented as mean ± SD. The pharmacokinetics parameters were presented as mean of six rats ± SD.
RESULTS
Plasma-extracted caffeic acid
The method of extraction of caffeic acid from plasma was found to be appropriate because no interference of endogenous compounds of the plasma was observed (Figure 2 and 3) . In this method, the retention time of caffeic acid was found to be 3.1 min, which was lesser than some of the studies, wherein it was 10.9 min and 15 min [21, 22] . These results indicated that by using the present procedure, analysis could be completed in lesser time and consuming fewer solvents.
Validity of the method
The method was found to be linear in the whole range of samples investigated (2.5-100.0 µg/mL) with the linear regression equation (Y = 0.258+0.1744) and R 2 = 0.9991. This equation indicated that the plot was linear and the intercept was almost approaching to zero. Useful range was determined that could be used to quantify the drug in the samples. Moreover, peak symmetry and capacity factor indicated that the method was specific.
The results of LOD and LOQ values of caffeic acid were found to be 0.70 µg/mL and 2.12 µg/mL, respectively, which indicated that the method was sensitive. The results of the recovery, intraday and inter day accuracy and precision are given in Table 1 . The mean recovery was found to be 96.09 -98.43 % with relative standard deviation less than 5 %. Intraday and inter day accuracy was found to be 96.09 -98.43 % and 90.86 -97.93 % respectively, with relative standard deviation less than 5 %. This indicated that the method was reliable, accurate and precise. Moreover, the method was found to be robust because it was not affected by a small change in mobile phase composition, column temperature and detection wavelengths. 
Pharmacokinetic profile of caffeic acid
The plasma samples of each rat, taken at different time intervals were analyzed to determine the contents of caffeic acid, which were then used to calculate various pharmacokinetics parameters. The plasma concentration versus time curve (Figure 4 ) indicated that caffeic acid of the extract followed a fast and steady absorption, which reached the maximum at 1.00 h. The steady fall in the concentration from 1 -2 h showed disposition of caffeic acid from the plasma to more perfused tissues. After 2 h, elimination of the drug was found to be slow which indicated the excretion from plasma and dynamic equilibrium by moving the drug from tissue to blood.
The pharmacokinetics of caffeic acid is given in Table 2 . These results showed that the absorption of caffeic acid from the oral route was quite fast, followed by a biphasic elimination. Mean resident time and volume of distribution (4 h) indicated that the body was exposed to the drug for a lesser time. The fast decline in concentration may be due to disposition or metabolism. In the present study, an oral dose of the extract (500 mg/rat), equivalent to 37.135 mg, was administered and a much lesser amount was absorbed (C max = 15.2 µg/mL). Our results were found to be consistent to that reported earlier. The report indicated that 20 % of the dose of caffeic acid was absorbed into enterocytes from the intestine, from where only 19.5 % (0.5 % secreted into the intestine) passed into mesenteric vein leading to the liver wherein the concentration was further decreased due to biliary secretion (0.4 %) resulting 19.1 % bioavailability to peripheral tissues [21] .
DISCUSSION
The separation of caffeic acid from rat plasma was achieved using solvent extraction. For such purpose, a combined approach-deproteination and liquid-liquid extraction-was employed. Deproteination was achieved using acetonitrile and extraction was carried out using methanol. The varying amounts of acetonitrile were used to achieve de-proteination. Acetonitrile (200 µL) was found to be enough to de-protein 500 µL of the rat plasma. Likewise, 800 µL of methanol gave more than 95 % recovery, which indicated that the method is good to be used to study pharmacokinetics of extracts of seeds of the plant. Moreover, the method was found to be accurate, precise and robust.
The drug must reach quickly at the site of action in a suitable concentration. At the same time drug must be eliminated from the body in lesser time to avoid the drug exposure. In the present study, caffeic acid absorption from the gastrointestinal tract was fast, but in lower amount than the dose administered (19.1 %). The clearance (21.86 h) and volume of distribution (4.378) indicated that the drug will be safer as the exposure was for a lesser time.
Caffeic acid is a well-known phenolic compound, which is widely distributed in fruits and vegetables [23] . The compound is reported to have significant antioxidant activity [24] [25] [26] . However, results of the present study indicate that oral bioavailability of this compound needs to be enhanced to get the maximum benefit.
CONCLUSION
The results obtained indicate the low but fast oral bioavailability of caffeic acid from the methanol seed extract of Syzygium cumini. Peak plasma concentration is achieved in 1 h which suggests improved oral absorption of caffeic acid.
